Amanda Jacobson

Amanda Jacobson has a strong background in clinical science and medical writing. Amanda currently serves as the Senior Director Clinical Science at G1 Therapeutics, Inc., where they lead breast cancer clinical trials, supports program development plans, and co-leads a company initiative focused on diversity and inclusion in clinical trials. Prior to this role, Amanda served as the Director of Clinical Science at G1 Therapeutics, Inc.

Before joining G1 Therapeutics, Amanda worked at Pfizer as an Associate Director, Clinician, Early Clinical Development Oncology. Amanda also gained experience at AbbVie, where they held various roles including Associate Scientific Director, Clinical Scientist, and Principal and Senior Medical Writer in the Oncology department.

Earlier in their career, Amanda worked as a Medical Writer and Consultant at InClin, Inc., where they wrote regulatory documents, managed projects, and contributed to proposal development. Amanda also worked as a Medical Writer at Stanford University and as a Postdoctoral Scientist at the Seattle Biomedical Research Institute, where they focused on neonatal immune response, infant health, and vaccine development.

Overall, Amanda Jacobson has a diverse range of experience in clinical science, medical writing, and project management. Amanda has demonstrated expertise in leading and supporting clinical trials, collaborating cross-functionally, and contributing to regulatory strategies.

Amanda Jacobson holds a Ph.D. in Cell Biology and Immunology from the University of Utah. Before that, they completed their undergraduate studies at St. Olaf College, where they earned a Bachelor of Arts degree in Biology. Additionally, Amanda obtained certification in Clinical Safety and Pharmacovigilance from the Drug Information Association in March 2018.